The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...

Ozempic contains the active ingredient semaglutide. (An active ingredient is what makes a drug work.) It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists.

Ozempic (semaglutide) is an injectable medication ... and sleep habits. How it works: To get started, you complete an online visit, where you’re asked questions about your height, weight ...

Oral semaglutide reduced risk for major adverse CV events by 14% in high-risk adults with type 2 diabetes regardless of SGLT2 ...

Novo Nordisk presented new data from the retrospective, observational SCORE study that assessed treatment with semaglutide ...

Researchers suggest the 20% reduction in nonfatal heart attacks was the primary driver of this benefit for patients with type ...

The popular anti-obesity drug Mounjaro has finally been launched in India. The development comes after Eli Lilly received ...

Approved for treating obesity only in 2021, it is in short supply and is very expensive, but it has already had an extraordinary impact (“How semaglutide and similar drugs work”, below).

While we have found amazingly effective treatments—antibiotics for tuberculosis, antiretroviral therapy for HIV—any given drug almost always works for just one disease, and they typically come ...

The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...